ImmunoGen Message Board - Msg: 13377492

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don Hurst who wrote (2993)	4/7/2000 6:35:00 PM
From: Marty R	Read Replies (1) of 5665

I found this on Raging Bull. It's an excerpt from the SACI site. Does anyone track that site closely enough to know if this is a recent entry/update? The word CURE sure looks nice in there. SACI SITE INFO SB408075 Humanized monoclonal antibody to the antigen C242 (found on more than 90% of colorectal and pancreatic cancers, as well as other carcinomas). It is attached to the chemotherapeutic agent maytansine. This conjugate has induced prominent activity, including cures, in well-established tumors in preclinical studies. Given once every 3 weeks. (Approved at BAMC.) Consider for all solid tumors, but particularly for colon, pancreas, lung, breast, prostate, bladder, and other carcinomas.)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next